CVE-2025-12995
Medtronic · Medtronic Multiple Products (specifically the CareLink Network)
A high-severity vulnerability has been identified in the Medtronic CareLink Network, allowing an unauthenticated remote attacker to guess user passwords through a brute-force attack.
Executive summary
A high-severity vulnerability has been identified in the Medtronic CareLink Network, allowing an unauthenticated remote attacker to guess user passwords through a brute-force attack. Successful exploitation could lead to unauthorized access to sensitive patient health information and medical device data, posing a significant risk to patient privacy and data integrity. Organizations are urged to apply the vendor-provided security updates immediately to mitigate this threat.
Vulnerability
The vulnerability exists within an API endpoint of the Medtronic CareLink Network that lacks sufficient protection against automated login attempts. There are no rate-limiting or account lockout mechanisms in place. A remote, unauthenticated attacker can exploit this by using automated scripts to send a high volume of password guesses against a known username, a technique known as a brute-force attack. If a user has a weak or commonly used password, the attacker could eventually guess the correct credentials and gain unauthorized access to the account.
Business impact
This vulnerability is classified as High severity with a CVSS score of 8.1. The primary business impact is the potential for a significant data breach involving sensitive Protected Health Information (PHI). Unauthorized access to patient accounts could lead to the exposure of medical records, device readings, and personal data, resulting in severe regulatory penalties (e.g., under HIPAA), legal liabilities, and significant reputational damage. Furthermore, depending on the permissions granted by the compromised account, an attacker could potentially interfere with patient data, impacting patient care and safety and eroding trust in Medtronic's services.
Remediation
Immediate Action: Organizations must apply the security updates provided by Medtronic to all affected systems immediately. Prioritize patching systems that are part of or connect to the CareLink Network. Following the patch deployment, it is critical to monitor for any signs of ongoing or past exploitation attempts by thoroughly reviewing access logs for suspicious login patterns.
Proactive Monitoring: Implement and enhance monitoring on the affected API endpoints. Security teams should look for and alert on high volumes of failed authentication attempts originating from a single IP address or a distributed set of IP addresses. Monitor for unusual login patterns, such as multiple rapid login attempts against a single user account or successful logins from unexpected geographical locations.
Compensating Controls: If immediate patching is not feasible, implement compensating controls as a temporary measure. Deploy a Web Application Firewall (WAF) or an API gateway in front of the CareLink Network to enforce rate-limiting rules on the vulnerable authentication endpoint. This will block or slow down IP addresses that exceed a defined threshold of login attempts in a short period. Additionally, enforce a strong, complex password policy for all user accounts to increase the difficulty of a brute-force attack.
Exploitation status
Public Exploit Available: false
Analyst recommendation
Given the high CVSS score of 8.1 and the direct risk to sensitive patient health information, we strongly recommend that organizations prioritize the immediate application of the vendor-supplied patches. The lack of authentication required for an attacker to begin an assault makes this a critical vulnerability to address. While this CVE is not currently on the CISA KEV list, its potential impact on the healthcare sector means it should be treated with the utmost urgency. In addition to patching, organizations should validate that compensating controls like rate-limiting and robust account monitoring are in place to defend against similar threats in the future.